首页> 外文期刊>Modern Pathology >Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors
【24h】

Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors

机译:免疫组化在软组织肿瘤诊断和分类中的新用途

获取原文
           

摘要

Immunohistochemistry plays a key role in the diagnosis of soft tissue tumors. Until recently, however, the primary purpose of immunohistochemistry in this context was simply to attempt to demonstrate a line of differentiation. Unfortunately, most traditional markers (predominantly directed against cytoplasmic determinants) show relatively limited specificity. Over the last decade or so, much more specific immunohistochemical markers for soft tissue tumors have been developed. This review will provide an update of some of the most useful new diagnostic markers, which are significantly changing clinical practice for surgical pathologists, separated into three general categories: (1) lineage-restricted transcription factors, (2) protein correlates of molecular alterations, and (3) diagnostic markers identified by gene expression profiling.
机译:免疫组织化学在软组织肿瘤的诊断中起关键作用。然而,直到最近,在这种情况下免疫组织化学的主要目的仅仅是试图证明分化线。不幸的是,大多数传统标记(主要针对细胞质决定簇)显示相对有限的特异性。在过去的十年左右的时间里,已经开发出了针对软组织肿瘤的更加特异性的免疫组织化学标记。这篇评论将提供一些最有用的新诊断标记的更新,这些新诊断标记正在改变外科病理学家的临床实践,分为三大类:(1)谱系限制的转录因子,(2)分子改变的蛋白质相关性, (3)通过基因表达谱鉴定的诊断标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号